查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012715

血管造影術設備市場：按系統類型、檢測器類型、應用和最終用戶分類 - 2026-2032年全球市場預測

Angiography Equipment Market by System Type, Detector Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血管造影術設備市場價值將達到 140.8 億美元，到 2026 年將成長至 149.6 億美元，到 2032 年將達到 219.2 億美元，複合年成長率為 6.52%。

主要市場統計數據
基準年 2025 140.8億美元
預計年份：2026年 149.6億美元
預測年份 2032 219.2億美元
複合年成長率 (%) 6.52%

簡要概述診斷影像的準確性、介入治療需求和經濟壓力如何重新定義血管造影術系統的採購和臨床應用。

血管造影術系統代表了現代醫療服務中影像精度、介入能力和系統級整合三者的完美結合。本執行摘要概述了影響整個診斷和介入領域採購、臨床部署和技術進步的關鍵趨勢。它探討了系統結構、檢測器技術和臨床應用如何整合，從而對劑量管理、工作流程效率以及與電子健康記錄的互通性提出了新的要求。

數位檢測器、人工智慧成像和混合手術工作流程的進步如何融合，重新定義血管造影術系統的臨床效用和採購重點。

在血管造影術領域，技術成熟、臨床路徑不斷演進以及生態系統內夥伴關係的推動下，變革正在發生。在許多臨床環境中，數位平板檢測器技術正在取代傳統的影像增強管系統，從而提高影像品質和劑量效率，使更複雜、微創的手術成為可能。同時，軟體方面的進步，從即時降噪和血管增強到利用擴增實境（AR）疊加技術進行手術指導，正在增強醫生的信心並縮短手術時間。

美國關稅政策變化對製造商和醫療保健提供者的血管造影術系統採購、定價和籌資策略的多方面連鎖反應。

美國2025年實施的貿易政策轉變與關稅調整，為血管造影術設備的供應鏈與籌資策略增添了新的複雜性。這些措施影響了製造和分銷管道的成本結構，並推高了部分進口組件和成品的價格，同時也促進了某些生產活動的回流（將生產遷回本國）和近岸外包（將生產轉移到鄰國）。在組裝和校準過程中，專用檢測器面板、精密馬達和專有軟體模組需要多次跨境，因此這些措施的累積影響最為顯著。

從洞察深刻、以細分為導向的觀點系統結構、檢測器技術、臨床應用和最終用戶優先權與可操作的產品和服務策略連結起來。

詳細的市場區隔揭示了臨床需求、技術選擇和採購行為之間的交集，為供應商和醫療系統提供了切實可行的見解。根據系統類型，市場可分為雙平面系統和單平面系統。雙平面系統在需要同時進行正交成像的複雜神經血管和複雜結構介入手術中越來越受歡迎，而單平面系統由於其面積效率和成本優勢，在高通量心血管和外周介入手術室中仍然佔據主導地位。根據檢測器類型，在優先考慮影像解析度和劑量效率的環境中，平板檢測器的使用率顯著提高，而影像增強器系統在患者量較少或預算有限、優先考慮可靠性和低初始投資的醫療機構中仍然發揮著至關重要的作用。

區域醫療基礎設施、報銷制度和設備擴容如何影響血管造影術設備的採用趨勢和商業策略？

區域趨勢正以不同的方式影響血管造影術系統的應用路徑和競爭定位。在美洲，大規模醫院網路、心臟病學和介入放射學的高檢查量，以及對人工智慧輔助成像和與混合手術室相容等先進功能的需求，都在影響著投資模式。該地區的報銷框架和資本預算流程往往側重於已證實的臨床和經濟效益，從而鼓勵醫療機構優先選擇兼具性能和生命週期價值的系統。

我們在血管造影術領域的競爭優勢源於一個整合的硬體和軟體生態系統，有助於技術的採用、本地化的卓越服務以及經過驗證的臨床夥伴關係。

血管造影術設備市場的競爭格局以產品差異化、服務生態系統和策略夥伴關係為特徵。主要企業正著力打造整合解決方案，將高效能成像硬體與先進的軟體工具集結合，用於工作流程協調、遠距離診斷和手術規劃。這種系統級方案使供應商能夠透過服務合約、軟體訂閱和耗材銷售獲得持續收入，同時為客戶提供可預測的生命週期成本。

為製造商和醫療保健領導者提供切實可行的策略建議，以加速血管攝影檢查系統的採用，減少採購摩擦，並提高臨床價值的實現。

產業領導者需要調整其商業策略，使其與不斷變化的臨床需求和採購行為相適應，從而在血管造影術生態系統中實現永續價值。首先，他們應優先考慮模組化和可升級的產品架構，以便在不更換整個系統的情況下分階段引入先進的檢測器單元、軟體功能和手術輔助設備。這將降低採購門檻，並減輕關稅對價格波動的影響。其次，他們應投資於嵌入式的臨床決策支援和手術指導工具，這些工具可以顯著縮短手術時間、造影造影劑用量和輻射曝射量。臨床證據和同行評審的檢驗結果很可能對懷疑的買家產生重大影響，促使他們接受這些工具。

透過結合與專家的初步訪談、系統性的次要分析和三角檢驗，高度透明和多方面的調查方法確保了可重複和引人注目的見解。

我們的調查方法結合了對醫療保健相關人員的結構化一手訪談、對二手資訊的全面整合以及嚴謹的檢驗驗證，從而確保了研究結果的可靠性和可操作性。一手研究包括對介入性心臟病專家、介入神經放射學專家、放射科醫生、生物醫學工程師、採購主管和獨立服務機構的深入訪談，旨在了解他們對臨床需求、服務期望和採購行為的實際觀點。這些訪談旨在獲取關於系統性能、維護經驗和決策標準的真實見解。

一項權威的綜合分析突顯了供應商和醫療保健提供者在不斷發展的血管造影術領域中，在協調創新、服務和採購方面所面臨的戰略挑戰。

總之，在檢測器技術進步、內建軟體功能增強以及臨床工作流程向混合和微創方法轉變的推動下，血管造影術系統目前正經歷著重大變革。能夠提供模組化架構、檢驗的臨床決策支援和完善服務模式的供應商，最能滿足醫院、專科診所和診斷中心的多樣化需求。貿易政策和關稅趨勢凸顯了靈活採購和商業條款的重要性，有助於保護客戶免受成本快速波動的影響，同時維持供應商的利潤率。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章血管造影術設備市場（依系統類型分類）

  • 雙翼飛機
  • 單翼飛機

第9章：檢測器類型分類的血管造影術設備市場

  • 平板
  • 影像增強器

第10章血管造影術設備市場：依應用領域分類

  • 循環系統
    • 冠狀動脈
    • 外圍
  • 神經病學
    • 腦
    • 脊髓
  • 放射科
    • 腹部
    • 外圍

第11章血管造影術設備市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 專科診所

第12章血管造影術設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章血管造影術設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章血管造影術設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血管造影術設備市場

第16章 中國血管造影術器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health Inc.
  • Electron Co.
  • GE Healthcare
  • General Electric Company
  • Hitachi Medical Systems Corporation
  • Koninklijke Philips NV
  • Koninklijke Philips NV
  • Medical Warehouse
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Toshiba Corporation
Product Code: MRR-43690106627D

The Angiography Equipment Market was valued at USD 14.08 billion in 2025 and is projected to grow to USD 14.96 billion in 2026, with a CAGR of 6.52%, reaching USD 21.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.08 billion
Estimated Year [2026] USD 14.96 billion
Forecast Year [2032] USD 21.92 billion
CAGR (%) 6.52%

A concise orienting overview of how imaging precision, interventional demand, and economic pressures are redefining procurement and clinical use of angiography systems

Angiography equipment sits at the intersection of imaging precision, interventional capability, and system-level integration within modern healthcare delivery. This executive summary distills the pivotal dynamics shaping procurement, clinical adoption, and technology evolution across diagnostic and interventional suites. It examines how system architectures, detector technologies, and clinical applications are converging to drive new requirements for dose management, workflow efficiency, and interoperability with electronic health records.

Clinicians demand higher spatial and temporal resolution to support complex procedures in cardiology, neurology, and radiology, while hospital administrators prioritize lifecycle costs, throughput, and downstream revenue capture. Simultaneously, suppliers are advancing digital detectors, AI-enabled image enhancement, and modular service offerings to meet heterogeneous customer needs. The interplay between clinical imperatives and capital constraints is producing differentiated value propositions that favor flexible financing, managed service models, and retrofit pathways for legacy installations.

This introduction frames subsequent sections that explore transformative shifts in the technology landscape, regulatory and trade policy impacts, segmentation-driven opportunities, regional patterns of adoption, competitive behavior among device manufacturers, and pragmatic recommendations for healthcare providers and suppliers aiming to navigate this rapidly evolving domain.

How digital detector advances, AI-enabled imaging, and hybrid procedural workflows are converging to redefine clinical utility and procurement priorities for angiography systems

The angiography landscape is experiencing transformative shifts driven by technological maturation, clinical pathway evolution, and ecosystem partnerships. Digital flat detector technology has steadily supplanted legacy image intensifier systems in many clinical environments, yielding improved image quality and dose efficiency that enable more complex minimally invasive procedures. Parallel advances in software-ranging from real-time noise reduction and vessel enhancement to procedural guidance using augmented overlays-are enhancing operator confidence and reducing procedure times.

At the same time, the boundaries between imaging equipment, informatics, and procedural devices are blurring. Integration with electronic health records and picture archiving systems is becoming table stakes, while open architectures and standardized data formats facilitate third-party analytics, remote monitoring, and predictive maintenance. Artificial intelligence is moving from pilot projects to embedded features that assist in anatomy segmentation, device navigation, and quality control, thereby improving consistency across operators and sites.

Clinical practice trends are also reshaping demand profiles. Interventionalists increasingly prefer systems that support hybrid procedures, allowing seamless transitions between diagnostic imaging and complex interventions. This has elevated interest in biplane systems for certain neurovascular and structural heart procedures, while monoplane systems are optimized for high-volume cardiology and peripheral workflows. Together, these forces are prompting manufacturers and healthcare providers to rethink procurement criteria, capital allocation, and long-term service agreements.

The multifaceted ripple effects of US tariff policy changes on sourcing, pricing, and procurement strategies for angiography systems across manufacturers and healthcare providers

Trade policy shifts and tariff adjustments introduced in the United States in 2025 added a new dimension of complexity to supply chain and procurement strategies for angiography equipment. These measures influenced cost structures along manufacturing and distribution channels, creating upward pressure on component and finished-system prices for some imported assemblies while incentivizing reshoring and nearshoring of select production activities. The cumulative impact has been most pronounced where specialized detector panels, precision motors, and proprietary software modules cross borders multiple times during assembly and calibration.

As a result, original equipment manufacturers reassessed sourcing footprints and supplier contracts to mitigate tariff exposure. Several providers accelerated dual-sourcing strategies and invested in qualifying local suppliers for critical subassemblies to preserve delivery timelines and stabilize pricing for major healthcare clients. Hospitals and integrated delivery networks responded by intensifying vendor negotiations, seeking favorable service terms, and evaluating total cost of ownership more rigorously, including spare parts availability and long-term maintenance commitments.

Procurement teams also began to place higher value on modular product designs that allow phased upgrades without full-system replacement, thereby reducing capital outlays that are sensitive to tariff-induced price volatility. In parallel, distributors and systems integrators adapted commercial models to offer expanded financing, extended warranties, and inventory pooling solutions that buffer customers from sudden cost escalations. These market adaptations highlight the interconnectedness of trade policy, manufacturing strategy, and clinical technology adoption.

Insightful segmentation-driven perspectives linking system architecture, detector technology, clinical application, and end-user priorities to actionable product and service strategies

Granular segmentation illuminates where clinical needs intersect with technology choice and procurement behaviors, offering actionable insight for suppliers and health systems. Based on system type, the landscape separates into biplane systems, which are increasingly favored for complex neurovascular and combined structural interventions that demand simultaneous orthogonal imaging, and monoplane systems, which continue to dominate high-throughput cardiology and peripheral interventional suites due to their footprint efficiency and cost profile. Based on detector type, the shift toward flat panel detectors is evident in settings that prioritize image resolution and dose efficiency, while image intensifier systems remain relevant in lower-volume or budget-constrained facilities that prioritize proven reliability and lower immediate capital expenditure.

Based on application, clinical demand patterns vary: cardiology drives a large share of procedure volume and favors systems optimized for coronary and peripheral vascular access, neurology requires specialized neuro-vascular capabilities tailored to cerebral and spinal interventions with high spatial resolution and rapid imaging sequences, and radiology applications focus on abdominal and peripheral vascular work where contrast dynamics and soft-tissue visualization are critical. Based on end user, diagnostic centers emphasize throughput and serviceability to support ambulatory care models, hospitals require scalable platforms that integrate into surgical and hybrid operating rooms while balancing capital constraints and multidisciplinary use, and specialty clinics prioritize compact, procedure-specific systems that deliver procedural efficiency and straightforward maintenance.

Understanding these segmentation lenses in combination enables suppliers to tailor product roadmaps, service packages, and pricing strategies that align with distinct clinical workflows and procurement cycles across customer cohorts.

How regional healthcare infrastructure, reimbursement mechanisms, and capacity expansion are driving differentiated adoption trends and commercial strategies for angiography equipment

Regional dynamics shape adoption pathways and competitive positioning for angiography equipment in distinct ways. In the Americas, investment patterns are influenced by large hospital networks, high procedure volumes in cardiology and interventional radiology, and an appetite for advanced features such as AI-assisted imaging and hybrid-suite compatibility. Reimbursement frameworks and capital budgeting processes in this region tend to favor demonstrable clinical and economic benefits, prompting providers to prioritize systems that offer both performance and lifecycle value.

In Europe, Middle East & Africa, heterogeneous healthcare infrastructures lead to a spectrum of adoption behaviors: advanced tertiary centers and academic hospitals invest in biplane and high-spec flat detector systems to support complex neurovascular and structural interventions, while mid-tier hospitals and clinics may favor monoplane or retrofittable solutions that balance capability with cost. Regulatory harmonization and cross-border procurement in certain subregions influence vendor strategies and create opportunities for service-based commercial models.

In Asia-Pacific, rapid expansion of procedural capacity, growing private healthcare sectors, and government-led investments in tertiary care facilities are driving demand for both new installations and upgrade pathways. High-volume centers prioritize throughput, remote serviceability, and local training partnerships, while emerging markets exhibit sensitivity to acquisition cost and aftermarket support, encouraging manufacturers to offer flexible financing and localized maintenance networks. These regional patterns underscore the need for nuanced go-to-market approaches that align product variants and commercial models with local clinical and economic realities.

Competitive differentiation in angiography emerges from integrated hardware-software ecosystems, localized service excellence, and validated clinical partnerships that drive adoption

Competitive dynamics among companies in the angiography equipment space are characterized by product differentiation, service ecosystems, and strategic partnerships. Leading manufacturers emphasize integrated solutions that couple high-performance imaging hardware with advanced software toolsets for workflow orchestration, remote diagnostics, and procedure planning. This systems-level approach allows vendors to capture recurring revenue through service contracts, software subscriptions, and consumables while offering customers predictable lifecycle costs.

Strategic alliances with clinical centers and academic institutions play a critical role in validating technology and accelerating clinical acceptance, particularly for innovations such as AI-enabled image guidance and dose-optimization algorithms. In addition, regional distributors and service partners contribute materially to market penetration by providing localized training, rapid maintenance response, and spare-part inventories that sustain uptime in high-volume procedural settings.

Smaller and niche suppliers find opportunities by focusing on specialized segments-such as compact systems for outpatient clinics, retrofit detector solutions for legacy C-arms, or dedicated neurovascular platforms-where agile product development and targeted service offerings can outmaneuver broader incumbents. Across the competitive landscape, clear differentiation arises from demonstrated clinical outcomes, total cost of ownership transparency, and the ability to support multidisciplinary use cases within contemporary hybrid operating environments.

Practical and strategic recommendations for manufacturers and healthcare leaders to accelerate adoption, reduce procurement friction, and enhance clinical value delivery for angiography systems

Industry leaders should align commercial strategies with evolving clinical demands and procurement behaviors to capture sustainable value in the angiography ecosystem. First, prioritize modular and upgradable product architectures that allow customers to phase in advanced detector units, software capabilities, and procedural adjuncts without full-system replacement, thereby lowering barriers to purchase and reducing sensitivity to tariff-driven price volatility. Second, invest in embedded clinical decision support and procedure guidance tools that demonstrably reduce procedure time, contrast usage, and radiation dose; clinical evidence and peer-reviewed validation will materially influence adoption among skeptical buyers.

Third, develop flexible commercial models including managed services, outcome-linked pricing, and extended warranties that address capital constraints and shift some performance risk away from buyers. Fourth, strengthen local service networks and spare-part distribution in strategic regions to improve uptime guarantees and build trust with high-volume centers. Fifth, cultivate academic and clinical center partnerships to co-develop workflow-optimized solutions and to generate real-world evidence supporting improved clinical outcomes. Finally, enhance interoperability with hospital informatics and third-party analytics platforms to ensure seamless integration into enterprise imaging strategies and to unlock value from procedural data for quality improvement and research initiatives.

A transparent, multi-source research methodology blending expert primary interviews, systematic secondary analysis, and triangulation to ensure replicable and defensible insights

Our research methodology combined structured primary engagement with healthcare stakeholders, comprehensive secondary-source synthesis, and rigorous triangulation to ensure robust and actionable findings. Primary research included in-depth interviews with interventional cardiologists, neurointerventionalists, radiologists, biomedical engineers, procurement executives, and independent service organizations to capture frontline perspectives on clinical requirements, service expectations, and purchasing behavior. These conversations were designed to surface unfiltered insights on system performance, maintenance experience, and decision criteria.

Secondary research involved a systematic review of publicly available regulatory approvals, clinical literature, professional society guidelines, and industry white papers to contextualize technological developments and procedural trends. Data triangulation merged qualitative insights with product release timelines, patent activity, and supplier announcements to validate adoption signals and strategic direction across manufacturers. Emphasis was placed on reproducibility: methodologies and interview frameworks were documented, and findings were cross-checked against multiple independent sources.

Limitations of the methodology include variability in regional reporting practices and the evolving nature of software-enabled features that may reach different markets at different times. To mitigate these factors, sensitivity assessments were applied when drawing conclusions about supply chain adjustments and regional adoption patterns.

A decisive synthesis highlighting the strategic imperatives for suppliers and healthcare providers to align innovation, service, and procurement in the evolving angiography domain

In conclusion, angiography equipment is undergoing a period of substantive transformation driven by advances in detector technology, embedded software capabilities, and changing clinical workflows that favor hybrid and minimally invasive approaches. Suppliers that offer modular architectures, validated clinical decision support, and resilient service models will be best positioned to meet the nuanced needs of hospitals, specialty clinics, and diagnostic centers. Trade policy and tariff developments have underscored the importance of flexible sourcing and commercial terms that protect customers from abrupt cost shifts while preserving supplier margins.

Regional adoption patterns vary, requiring tailored strategies that reflect reimbursement environments, infrastructure maturity, and local service expectations. Segmentation across system type, detector type, clinical application, and end user offers a practical framework for prioritizing product development and go-to-market investments. Ultimately, success in this market hinges on the ability to deliver demonstrable clinical value, predictable lifecycle economics, and seamless integration into existing enterprise workflows. Stakeholders who align innovation roadmaps with these imperatives will accelerate adoption, improve procedural outcomes, and capture long-term commercial advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angiography Equipment Market, by System Type

  • 8.1. Biplane
  • 8.2. Monoplane

9. Angiography Equipment Market, by Detector Type

  • 9.1. Flat Panel
  • 9.2. Image Intensifier

10. Angiography Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary
    • 10.1.2. Peripheral
  • 10.2. Neurology
    • 10.2.1. Cerebral
    • 10.2.2. Spinal
  • 10.3. Radiology
    • 10.3.1. Abdominal
    • 10.3.2. Peripheral

11. Angiography Equipment Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Angiography Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Angiography Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Angiography Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Angiography Equipment Market

16. China Angiography Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Boston Scientific Corporation
  • 17.7. Boston Scientific Corporation
  • 17.8. Canon Medical Systems Corporation
  • 17.9. Canon Medical Systems Corporation
  • 17.10. Cardinal Health, Inc.
  • 17.11. Carestream Health Inc.
  • 17.12. Electron Co.
  • 17.13. GE Healthcare
  • 17.14. General Electric Company
  • 17.15. Hitachi Medical Systems Corporation
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Medical Warehouse
  • 17.19. Medtronic plc
  • 17.20. MicroPort Scientific Corporation
  • 17.21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.22. Shimadzu Corporation
  • 17.23. Shimadzu Corporation
  • 17.24. Siemens Healthineers AG
  • 17.25. Stryker Corporation
  • 17.26. Terumo Corporation
  • 17.27. Toshiba Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY BIPLANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY MONOPLANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY FLAT PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CEREBRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)